Paper 1 : Abstract: Three-dimensional printing technology, also called additive manufacturing technology, is
used to prepare personalized 3D-printed drugs through computer-aided model design. In recent
years, the use of 3D printing technology in the pharmaceutical field has become increasingly sophisticated. In addition to the successful commercialization of Spritam® in 2015, there has been a succession
of Triastek’s 3D-printed drug applications that have received investigational new drug (IND) approval from the Food and Drug Administration (FDA). Compared with traditional drug preparation
processes, 3D printing technology has significant advantages in personalized drug manufacturing,
allowing easy manufacturing of preparations with complex structures or drug release behaviors and
rapid manufacturing of small batches of drugs. This review summaries the mechanisms of the most
commonly used 3D printing technologies, describes their characteristics, advantages, disadvantages,
and applications in the pharmaceutical industry, analyzes the progress of global commercialization
of 3D printed drugs and their problems and challenges, reflects the development trends of the 3D
printed drug industry, and guides researchers engaged in 3D printed drugs

Paper 2 :  Abstract: Three-dimensional (3D) printing is an additive manufacturing technique that creates objects
under computer control. Owing to the rapid advancement of science and technology, 3D printing
technology has been widely utilized in processing and manufacturing but rarely used in the pharmaceutical field. The first commercial form of Spritam® immediate-release tablet was approved
by FDA in 2015, which promoted the advancement of 3D printing technology in pharmaceutical
development. Three-dimensional printing technology is able to meet individual treatment demands
with customized size, shape, and release rate, which overcomes the difficulties of traditional pharmaceutical technology. This paper intends to discuss the critical process parameters of binder jet 3D
printing technology, list its application in pharmaceutical manufacturing in recent years, summarize
the still-open questions, and demonstrate its great potential in the pharmaceutical industry


Paper 3 : Abstract:
The technological revolution has physically affected all manufacturing domains, at the
gateway of the fourth industrial revolution. Three-dimensional (3D) printing has already shown its
potential in this new reality, exhibiting remarkable applications in the production of drug delivery
systems. As part of this concept, personalization of the dosage form by means of individualized
drug dose or improved formulation functionalities has concentrated global research efforts. Beyond the manufacturing level, significant parameters must be considered to promote the real-time
manufacturing of pharmaceutical products in distributed areas. The majority of current research
activities is focused on formulating 3D-printed drug delivery systems while showcasing different
scenarios of installing 3D printers in patients’ houses, hospitals, and community pharmacies, as
well as in pharmaceutical industries. Such research presents an array of parameters that must be
considered to integrate 3D printing in a future healthcare system, with special focus on regulatory
issues, drug shortages, quality assurance of the product, and acceptability of these scenarios by
healthcare professionals and public parties. The objective of this review is to critically present the
spectrum of possible scenarios of 3D printing implementation in future healthcare and to discuss the
inevitable issues that must be addressed.



Combine above three paper abstract and make one for report writing